LEVOCETIRIZINE ZENTIVA 5 mg, film-coated tablet 14 tablets, CIP 3400922194356
Active ingredients: Levocetirizine dihydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet14 tablets, CIP 3400922194356orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LEVOCETIRIZINE ZENTIVA 5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène PVC-Aluminium de 14 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Jul 2012
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61881763CIP72219435CIP133400922194356Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DICHLORHYDRATE DE LÉVOCÉTIRIZINEcomprimé | 5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: LEVOCETIRIZINE (DICHLORHYDRATE DE) 5 mg – XYZALL 5 mg, comprimé pelliculé.